𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Genetic diversity of human papillomavirus type 16 E6, E7, and L1 genes in Italian women with different grades of cervical lesions

✍ Scribed by Valeria Cento; Massimo Ciccozzi; Luigi Ronga; Carlo Federico Perno; Marco Ciotti


Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
154 KB
Volume
81
Category
Article
ISSN
0146-6615

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

High‐risk human papillomaviruses (HPVs) are risk factors for the development of cervical cancer. HPV 16 is the most common type, being present in about 60% of cervical cancers worldwide. Previous studies have reported upon the association between HPV 16 E6 variants and increased risk of cervical intraepithelial neoplasia and invasive cervical cancer. In this study, the presence of HPV 16 polymorphisms in the E6, E7, and L1 genes was investigated in relation to the presence of high‐grade lesions. Sequencing of the E6 gene revealed the presence of nucleotide mutations resulting in 15 amino acid changes. Of these, the G134D and C136R fall within the CXXC zinger finger domain important for p53 binding. In the E7 gene, four nucleotide variations were identified with two leading to the amino acid substitutions L15V and S31R. The L1 gene showed 13 nucleotide changes leading to 11 amino acid substitutions. Among these, the R364C and N367D are located at the base of the HI‐loop of the L1 protein, considered to be the immunodominant epitope of HPV 16. No significant relationship between HPV 16 variants and high‐grade lesions was found. Phylogenetic analysis showed that all the HPV 16 variants identified belonged to the European lineage, except one which was of the Asian‐American lineage. The European‐350G variant was detected most frequently (22 of 34, 64.7%). The study provides some new data on the genetic diversity of HPV 16 which may help to understand the oncogenic potential of the virus and to improve management of patients. J. Med. Virol. 81:1627–1634, 2009. © 2009 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Analysis of human papillomavirus type-16
✍ Maria Lina Tornesello; Maria Luisa Duraturo; Immacolata Salatiello; Luigi Buonag 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 129 KB 👁 1 views

## Abstract Human papillomavirus type 16 (HPV‐16) classes (E, AA, As, Af1, Af2) and their variants have different geographic distribution and different degrees of association with cervical lesions. This study was designed to examine HPV‐16 variants among Italian women and their prevalence in case p

T-cell response to human papillomavirus
✍ Paul K.S. Chan; Shih-Jen Liu; Jo L.K. Cheung; T.H. Cheung; Winnie Yeo; Pele Chon 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB 👁 1 views

## Abstract The E6 and E7 proteins encoded by human papillomaviruses (HPV) are prime targets for therapeutic vaccine development. Ninety‐five women with HPV 52 infection (33 transient infections, 17 cervical intraepithelial neoplasia grade II, 15 cervical intraepithelial neoplasia grade III, and 30

single-cell cytokine analysis allows det
✍ Jo-Ann S. Passmore; Vanessa C. Burch; Enid G. Shephard; Dianne J. Marais; Bruce 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB

## Abstract Specific types of human papillomavirus (HPV) are known to play a causal role in the development of cervical cancer, with human papillomavirus type 16 (HPV‐16) identified as the predominant type. Despite this, little is known about cervical immune responses to this pathogen. The aim of t

Immunoglobulin-A and -G responses agains
✍ Toshiyuki Sasagawa; Hiroshi Yamazaki; Yu-Zhen Dong; Shin-ichirou Satake; Masaya 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 155 KB 👁 2 views

## Immunoglobulin -A and -G (IgA and IgG) responses against HPV-16-like particles (VLP) were tested by ELISA in 104 women with cervical abnormalities, 26 atypical cells of undetermined significance (ASCUS) and 14 cytologically normal women with HPV DNA. As controls, 130 age-matched cytologically n